Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Follow-up of the FRUIT-RCT: aspirin resistance and cardiovascular risk factors after recurrent hypertensive disorders in pregnancy
2014-004739-38Phase 4Active
- Sponsor
- Amsterdam UMC
- Start
- Mar 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of aspirin in maternal hypertension (HDP) and cardiometabolic risk (CMR) (2 arms), sponsored by Amsterdam UMC. Primary endpoint: Aspirin resistance measured by multiple assays. Started Mar 2015; status: active.
02
Drugs
aspirin
03
Conditions
maternal hypertension (HDP)cardiometabolic risk (CMR)
Beyond the preview
Go deeper on 2014-004739-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-004739-38.